A fully integrated system that combines extended gate field-effect transistor (EGFET)-based potentiometric biosensors and electrochemical impedance spectroscopy (EIS)-based biosensors has been demonstrated. This integrated configuration enables the sequential measurement of the same immunological binding event on the same sensing surface and consequently sheds light on the fundamental origins of sensing signals produced by FET and EIS biosensors, as well as the correlation between the two. Detection of both the bovine serum albumin (BSA)/anti-BSA model system in buffer solution and bovine parainfluenza antibodies in complex blood plasma samples was demonstrated using the integrated biosensors. Comparison of the EGFET and EIS sensor responses reveals similar dynamic ranges, while equivalent circuit modeling of the EIS response shows that the commonly reported total impedance change (ΔZtotal) is dominated by the change in charge transfer resistance (Rct) rather than surface capacitance (Csurface). Using electrochemical kinetics and the Butler-Volmer equation, we unveil that the surface potential and charge transfer resistance, measured by potentiometric and impedance biosensors, respectively, are, in fact, intrinsically linked. This observation suggests that there is no significant gain in using the FET/EIS integrated system and leads to the demonstration that low-cost EGFET biosensors are sufficient as a detection tool to resolve the charge information of biomolecules for practical sensing applications.
The ability to detect biochemical species rapidly without complicated sample preparations in a centralized laboratory is essential for medical care, disease diagnosis, food safety, and environmental monitoring. Optical biosensing that requires secondary markers to label target biomolecules (e.g., fluorescence spectroscopy) is time consuming in sample preparation and response.1 In contrast, label-free electrical biosensors are particularly promising as point-of-care sensor devices since they can be miniaturized through cost-effective microfabrication. Relying directly on the immunological affinity between immobilized surface probes and targets in an analyte solution, the resulting change of the surface properties is amplified and converted into an electrical output signal by a transducer. Potentiometric and impedance biosensors are two of the most common transducers for label-free biosensing. Potentiometric biosensors detect the change of surface potential under DC operation due to the attachment of charged target biomolecules to the probes on the sensing surface and are most commonly implemented in the form of ion-sensitive FETs (ISFETs) or in a similar but a simplified configuration—extended gate FETs (EGFETs).2–5 Alternatively, impedance biosensors use electrochemical impedance spectroscopy (EIS) to measure the change of electrical current and, in turn, the electrical impedance of a biological interface under DC bias and AC oscillation.6–9 Cost-effective potentiometric and impedance sensors are capable of label-free operation that both simplifies the sample preparation steps and enables on-site detection with a shorter turnaround time.
Although various nanomaterial-based ISFETs have been used for potentiometric biosensors including silicon nanowires,10 graphene,11 carbon nanotubes,12 we have reported that the sensitivity of a potentiometric biosensor is independent of the choice of the transducer and instead relies only on the sensing surface.4 Moreover, ISFETs require a sophisticated encapsulation scheme to protect the semiconductor device from exposure to the liquid environment that can hamper reliability and stability.13 Consequently, if either the sensing surface or the readout component fails, the entire ISFET sensor becomes unusable. EGFET biosensors, by contrast, provide a simpler and a more robust design for liquid phase sensing by separating the sensing chip (an extended gate) from the readout transducer (FET), and the sensitivity is comparable to the conventional ISFET.4 Moreover, the EGFET is a promising tool for disease diagnosis with a comparable performance to ELISA (enzyme-linked immunosorbent assay) and SPR (surface plasmon resonance).5 Finally, since the transducer is separated from the sensing surface, the EGFET configuration readily enables the integration of potentiometric sensors with other sensor platforms.
EIS-based impedimetric biosensors measure change of impedance when species attach to the sensing surface. Under faradaic operation involving redox couples, the measured impedance spectrum can be further analyzed using an equivalent circuit model. Two of the most important parameters, charge transfer resistance (Rct) and surface capacitance (Csurface), can be resolved in this way. The change of surface potential and the formation of the biomolecular layer will prevent the redox species from approaching the working electrode due to electrostatic repulsion and steric hindrance, respectively.7 The phenomenon is often reflected in an increase of the Rct which dominates the overall measured impedance.
In this letter, we demonstrate a fully integrated system that combines both two-terminal EGFET-based potentiometric and three-terminal EIS-based impedance biosensing on a shared active sensing surface. This system enables the sequential measurement of the same binding event on the same sensing surface using two different sensing techniques. Consequently, we are able to perform a fundamental investigation into the origins of the sensing signal produced by FET and EIS biosensors. A bovine serum albumin (BSA) versus antibody-BSA (anti-BSA) prototype system was used as the test vehicle for the integrated biosensors. In addition, detection of bovine parainfluenza antibodies in a complex blood system with hemagglutinin-neuraminidase (HN) has also been demonstrated. Comparison of the EGFET and EIS sensor responses reveals similar dynamic ranges and motivates our study of the relationship between surface potential and impedance, which is explained by electrochemical kinetics and the Butler-Volmer equation.
All the chemicals and proteins were purchased from Sigma-Aldrich and used as received. The sensor chip was fabricated on a borofloat wafer. The metallic structures including the Au micro-strip working electrode (WE), Au (Ti/Au 10/90 nm) counter electrode (CE), and Pt (Ti/Pt 10/90 nm) on-chip pseudo-reference electrode (RE) were deposited and patterned using e-beam evaporation and photolithography, respectively. A commercial n-MOSFET (VN0104, Supertex) was used as the transducer for EGFET biosensors, and the I-V characterization was performed using a Keithley 4200-SCS semiconductor analyzer. EIS biosensors were characterized using a Gamry Interface 1000 potentiostat. The WE was coated with an o-aminobenzoic acid (o-ABA, 50 mM in H2SO4) carboxylated film through 10 cyclic voltammetry scans (0–0.8 V, 50 mV/s). The BSA proteins (1% in PBS) were immobilized onto the sensing surface through amine coupling using NHS/EDC. The contact time for BSA protein immobilization is 30 min. The sensing surface was later deactivated and blocked using 1 M ethanolamine-HCl solution for 30 min. This sensing surface was exposed to anti-BSA dilutions in PBS with a contact time of 20 min. The detailed experimental methods of HN/BPIV3 sensing can be found in the supplementary material. 10 mM hexaammineruthenium (III) chloride in PBS was used as the redox couple. In the EGFET sensor, the Au active sensing surface serves as the WE, i.e., extended gate of a MOSFET. A DC voltage sweep is applied to the liquid through a commercial Ag/AgCl RE. For the EIS sensor, the aforementioned Au WE is the active sensing surface. On-chip Pt pseudo-RE and Au CE are used. The signal, i.e., surface potential, of potentiometric sensors was extracted from the Id-Vref curve as the Vref value when Id = 1 μA. The EIS spectra were modeled using ZView (Scribner Associates Inc.) by minimizing the chi square value. The detailed methods and parameters for the electrical measurement can be found in the supplementary material.
Comparing EGFET and EIS sensors, the Au working electrode plays a common role: an active sensing surface and WE. As a result, a fully integrated sensing system combining EGFET potentiometric and EIS impedance biosensors can be achieved by sharing a common Au WE as schematically shown in Fig. 1(a). Using this integrated system, the steps of chemical functionalization and biomolecular attachment can be achieved for both sensors concurrently. Furthermore, this design offers a direct comparison between potentiometric and impedance sensors because the same binding events will be measured on a shared sensing surface.
The scheme and the optical image of the integrated FET/EIS biosensor system. (a) The experimental setup of the integrated system. (b) The equivalent circuit model for the impedance spectroscopy. (c) and (d) The optical images of the biosensor chip and the enlarged view of the Au micro-strip working electrode.
The scheme and the optical image of the integrated FET/EIS biosensor system. (a) The experimental setup of the integrated system. (b) The equivalent circuit model for the impedance spectroscopy. (c) and (d) The optical images of the biosensor chip and the enlarged view of the Au micro-strip working electrode.
The optical image of the sensor chip is shown in Fig. 1(c), and the enlarged view of Au micro-strip WE in Fig. 1(d). The dimension of the Au micro-strip is 50 μm long and 0.8 μm wide (4 × 10−7 cm2). The use of a microscale electrode provides the benefit of minimizing the mass transfer limited behaviors in EIS at low frequency, due to the decreased diffusion length around the miniaturized working electrode.9,14,15 The conventional Randle circuit model comprises series resistance (Rs), surface capacitance (Csurface usually modeled using constant phase elements, CPE), Warburg resistance (W), and charge transfer resistance (Rct). When the nominal size of the working electrode decreases, the diffusion layer thickness decreases, and the current is less dependent on the diffusion of reacting species toward the WE.16 As a result, the mass transfer dominated W becomes negligible and the Randle circuit can be simplified to a simple RC circuit as shown in Fig. 1(b).17,18 The measured impedance spectra will be modeled using the simplified circuit model to extract the circuit elements, including Rct. Using an n-channel MOSFET as the transducer, a positive voltage is applied to the solution for FET biosensor measurement and, therefore, a redox probe that has negative redox potential is desired. As a result, hexaammineruthenium (III) chloride, which has both negative reduction and oxidation potentials, qualifies for the application in this study.
The FET/EIS integrated sensor's responses to the BSA versus anti-BSA system are shown in Fig. 2. The Id-Vref curve of the transistor will shift horizontally depending on the magnitude and the polarity of the change of surface potential on the Au sensing surface. This change of surface potential due to the attachment of charged antibodies to the WE, i.e., extended gate, was obtained using the change of the FET's threshold voltage (Vth). Figure 2(a) depicts the shift of Id-Vref curves of the potentiometric sensor in the positive direction in response to the increasing concentration of anti-BSA in the PBS, indicating that the anti-BSA (isoelectric point 4.8 – 5.2) is negatively charged in the PBS buffer (pH 7.4).19 Figure 2(b) shows the change of surface potential measured by a FET potentiometric sensor versus anti-BSA concentration on a linear scale and logarithmic scale [inset of Fig. 2(b)]. A typical Langmuir adsorption response with a gradual saturation toward a high antibody concentration was observed.4 Measuring the same binding event at the working electrode, the change of EIS spectra with respect to the anti-BSA concentration is presented in a Nyquist plot [Fig. 2(c)]. Taking advantage of the miniaturized working electrode, no obvious mass transfer limited characteristics were observed in the recorded impedance spectra, except a slight deviation from the semi-circle at low frequency (<5 Hz) and a further optimization of the WE may be needed. As a result, the change of surface properties on the sensing surface is mainly reflected through the change of Rct. As the anti-BSA concentration increases, the overall size of the semicircle increases, indicating an increase of Rct and total impedance. By fitting the impedance spectra with the equivalent circuit model [Fig. 1(b)], biomolecular binding-related circuit elements, Rct and Csurface, could be extracted. However, Csurface is relatively insensitive to the attachment of antibodies to the semipermeable biolayer (Fig. S1, supplementary material). Figure 2(d) shows the relationship between Rct and anti-BSA concentration. A similar Langmuir adsorption behavior with saturation at high anti-BSA concentration was again observed, showing integrated operation of a FET/EIS biosensor system. Furthermore, the similar response obtained from both sensing platforms suggests a possible correlation between surface potential and the impedance, which is explored in the following.
The responses of FET potentiometric and EIS impedance biosensors to anti-BSA concentrations. (a) The shift of Id-Vref curve measured with FET and (b) the FET signal (surface potential) in response to anti-BSA concentrations on a linear scale and logarithmic scale (inset). (c) Nyquist plots of impedance spectra measured with EIS and (d) the Rct change in response to anti-BSA concentrations on a linear scale and logarithmic scale (inset).
The responses of FET potentiometric and EIS impedance biosensors to anti-BSA concentrations. (a) The shift of Id-Vref curve measured with FET and (b) the FET signal (surface potential) in response to anti-BSA concentrations on a linear scale and logarithmic scale (inset). (c) Nyquist plots of impedance spectra measured with EIS and (d) the Rct change in response to anti-BSA concentrations on a linear scale and logarithmic scale (inset).
According to classical electrochemical kinetics, the electrical current that flows through the electrode is governed by the effective potential on the electrode surface.20 This relationship is expressed by the Butler-Volmer equation. Under bias conditions that deviate from equilibrium, i.e., Tafel behavior, the Butler-Volmer equation that links the charge transfer resistance and the surface potential can be simplified to20,21
where R0 = Eapp/FAK°C, F is the Faraday constant, A is the area of the working electrode, k0 is the standard rate constant, C is the concentration of the redox couple species at the electrolyte-electrode interface, transfer coefficient α is commonly assumed to be 0.5 for a symmetrical energy barrier, Eapp is the bias applied to the system, ΔV is the change of surface potential on the working electrode, q is the elementary charge of an electron, kB is Boltzmann's constant, and T is the temperature. It is reported that k0 exhibits a wide range from 10−9 to several hundred cm/s depending on the choice of the redox couple, the surface morphology of the WE, the formation of the biolayer, different charge transfer mechanisms, buffer concentration, etc.20,22,23 In effect, the Butler-Volmer equation predicts that Rct is exponentially related to the change of surface potential (ΔV). Figure 3 shows the relationship between Rct, measured with EIS, and the exponentiation of ΔV, i.e., exp(αqΔV/kBT), obtained from the FET. A high linearity is observed which agrees well with the prediction of the Butler-Volmer theory. The fitted R0 is 1.43 × 106 Ω and is comparable to the calculated value of 1.04 × 106 Ω, where A = 4 × 10−7 cm2, k0 is 1 cm/s for a simple electron transfer,23 and C is 10−5 mol/cm3. In the case of affinity sensors, the ΔV results from the binding of charged biomolecules to the surface, i.e., WE. EGFET sensors directly measure this surface potential change, which concurrently influences the electrical current and the resulting impedance measured by EIS sensors by increasing the hindrance for redox species from reaching the WE. This finding confirms that the origin of the sensing signals for both potentiometric biosensors and impedance biosensors is the change of surface potential. Also, the signal output from potentiometric biosensors can be linked to that of impedance biosensors using the Butler-Volmer equation.
The relationship between the exponentiation of change of surface potential (exp(αqΔV/kBT)) and the charge transfer resistance (Rct), measured with potentiometric and impedemetric biosensors, respectively. The linear relationship fits well into the Butler-Volmer equation and confirms that both potentiometric and impedance biosensors are charge sensitive.
The relationship between the exponentiation of change of surface potential (exp(αqΔV/kBT)) and the charge transfer resistance (Rct), measured with potentiometric and impedemetric biosensors, respectively. The linear relationship fits well into the Butler-Volmer equation and confirms that both potentiometric and impedance biosensors are charge sensitive.
Beyond the BSA/anti-BSA system, a complex serological system of bovine hemagglutinin-neuraminidase (HN) versus antibodies of bovine parainfluenza virus protein type-3 (BPIV3) in blood plasma samples was also tested.24 HN protein was immobilized on the shared WE via amine coupling as the probe against the BPIV3 proteins in the analyte solution. Similar to the BSA/aBSA system, similar trends of the dynamic range of FET and EIS sensors were observed. Again, the relationship between signals from potentiometric and impedance sensors, ΔV and Rct, respectively, is linked and agrees well with the Butler-Volmer theory (see supplementary material, Fig. S2). The results further confirm the correlation between potentiometric and impedance sensors and suggest that the electrical sensor is a promising tool for the disease diagnostic applications. The details of HN protein immobilization, sensing surface blocking, and detection of antibodies of BPIV3 can be found in the supplementary material.
Impedance spectroscopy is a powerful tool to analyze the interfacial properties for corrosion, coatings, batteries, solar cells, etc. through complex analysis of the frequency responses.25–29 Intuitively, surface impedance measured in EIS biosensors is expected to respond to both charge and mass of the biomolecules. However, for biosensor applications, the frequency response of surface capacitance is insensitive to the formation of the biomolecular layer on the sensing surface because (1) the biolayer is semipermeable and is not a good capacitor; and (2) the double layer capacitance dominates.6,7,18 As a result, it is difficult to resolve the mass-related properties of biomolecules alongside their charge information using impedance biosensors. The surface potential related Rct remains the dominating contribution for the sensing signal. In other words, the FET/EIS integrated sensing system provides little extra value in monitoring the charge information of biomolecules since the origin of the signal is linked. In this way, simple FET-based potentiometric biosensors provide sufficient information for practical biosensing applications.
To further illustrate their suitability for cost-effective and rapid point-of-care detection, large area Au extended gate sensor chips (0.1 cm2) were also prepared without the use of photolithography steps, instead using e-beam metal evaporation and patterning with shadow masks. The DC operation of the EGFET at steady state is not limited by the diffusion and, therefore, alleviates the constraints of using microscale electrodes. The BSA proteins were immobilized onto widely used thiol SAM through amine coupling. The sensor response of the large area Au chips is compared to the micro-strip sensors in Fig. 4. In both cases, the BSA/anti-BSA sensitivities are around 17–18 mV/decade change of anti-BSA concentration. The results indicate no sensitivity advantage to the micro-strip design in EGFET biosensor at steady state.
The comparison between EGFET biosensors using large area Au sensing surface (black square) and Au micro-strip (red circle). The BSA/anti-BSA sensitivities using either approach are comparable.
The comparison between EGFET biosensors using large area Au sensing surface (black square) and Au micro-strip (red circle). The BSA/anti-BSA sensitivities using either approach are comparable.
In conclusion, biosensing using an integrated two-sensor system that combines EGFET-based potentiometric biosensors and EIS-based impedimetric biosensors has been demonstrated. This integrated two-sensor system enables the direct comparison between two sensing techniques by monitoring the same biological layers on the sensing surface. The correlation between sensor signals—that is, surface potential and Rct from FET and EIS, respectively—was linked using the Butler-Volmer equation. The results suggest that both FET and EIS biosensors are sensitive to the change of surface potential due to the attachment of charged biomolecules to the sensing surface, whereas the mass-dependent value of Csurface does not vary significantly. For the detection of charge properties of biomolecules, the EIS/FET integrated sensing system provides little extra advantage. Therefore, EGFET biosensors are inherently sufficient as electrical transducers for label-free biomolecule detection, while providing the added benefits of rapid response and low-cost scalability. For scenarios where detailed information about both charge and mass properties of biomolecular targets is required, the FET/EIS integrated sensing system that we have proposed may be deployed to great effect. Future studies involving complex biofluids and advanced modeling will help to identify how the mass-related properties extracted from EIS can be leveraged.
See supplementary material for (1) details of electrical measurement and the integrated sensor operation; (2) the extracted capacitance response against different anti-BSA concentrations from EIS spectra; and (3) the detailed description and results of HN/BPIV3 animal disease sensing.
This work was supported by the National Science Foundation (NSF, through CBET Award No. 1264705); the Science Foundation Ireland under US-Ireland “Agri-Sense” Project (No. SFI12/US/I2476); and the Department for Employment and Learning, Northern Ireland (DELNI, Grant No. USI 039).